INCREASED RECOVERY OF SURFACTANT PROTEIN-A IN AIDS-RELATED PNEUMONIA

被引:119
作者
PHELPS, DS
ROSE, RM
机构
[1] BRIGHAM & WOMENS HOSP,BOSTON,MA 02115
[2] NEW ENGLAND DEACONESS HOSP,BOSTON,MA 02215
[3] HARVARD UNIV,SCH MED,DEPT MED,BOSTON,MA 02115
来源
AMERICAN REVIEW OF RESPIRATORY DISEASE | 1991年 / 143卷 / 05期
关键词
D O I
10.1164/ajrccm/143.5_Pt_1.1072
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Respiratory infection with Pneumocystis carinii (PC) is the most frequent serious opportunistic infection in the clinical setting of acquired immunodeficiency syndrome (AIDS). The factors responsible for the predisposition of human immunodeficiency virus (HIV)-infected patients for PC infection are not fully understood. We postulated that changes in the alveolar lining material (ALM) could play a role in the pathogenesis of PC infection in AIDS. We have compared constituents of ALM in bronchoalveolar lavage fluid from normal, nonsmoking volunteers with that of HIV-infected patients with pneumonia. Using an ELISA, we found that surfactant protein A (SP-A) was markedly elevated in the pneumonia patients. Mean SP-A values for the normal nonsmoking individuals (n = 21) were 1.50 +/- 0.25-mu-g/ml (mean +/- SEM). SP-A levels in the HIV-infected patients (n = 22) were significantly elevated (p < 0.01) with a mean of 5.23 +/- 0.54-mu-g/ml. This increase was greatest in the patients with more clinically severe pneumonia. The increase in SP-A did not appear to be pathogen-specific as it was also observed in cases of non-PC pneumonia. We also found that total protein levels were nearly five times higher in the HIV-infected pneumonia patients. These studies idicate that the protein component of the ALM is markedly different from normal in cases of HIV-associated PC and non-PC infection. Further investigation is needed to determine the mechanism of these alterations and their role, if any, in AIDS-related pneumonia.
引用
收藏
页码:1072 / 1075
页数:4
相关论文
共 24 条
[1]   MECHANISMS OF DAMAGE TO LUNG SURFACTANT SYSTEM - ULTRASTRUCTURE AND QUANTITATION OF NORMAL AND IN-VITRO INACTIVATED LUNG SURFACTANT [J].
BALIS, JU ;
SHELLEY, SA ;
MCCUE, MJ ;
RAPPAPORT, ES .
EXPERIMENTAL AND MOLECULAR PATHOLOGY, 1971, 14 (02) :243-+
[2]   PROGNOSTIC FACTORS AND LIFE EXPECTANCY OF PATIENTS WITH ACQUIRED-IMMUNODEFICIENCY-SYNDROME AND PNEUMOCYSTIS-CARINII PNEUMONIA [J].
BRENNER, M ;
OGNIBENE, FP ;
LACK, EE ;
SIMMONS, JT ;
SUFFREDINI, AF ;
LANE, HC ;
FAUCI, AS ;
PARRILLO, JE ;
SHELHAMER, JH ;
MASUR, H .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1987, 136 (05) :1199-1206
[3]   SURFACTANT-ASSOCIATED PROTEINS IN TRACHEAL ASPIRATES OF INFANTS WITH RESPIRATORY-DISTRESS SYNDROME AFTER SURFACTANT THERAPY [J].
CHIDA, S ;
PHELPS, DS ;
CORDLE, C ;
SOLL, R ;
FLOROS, J ;
TAEUSCH, HW .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1988, 137 (04) :943-947
[4]  
DAVIS GS, 1982, AM REV RESPIR DIS, V126, P611
[5]  
DRICKAMER K, 1986, J BIOL CHEM, V261, P6878
[6]   SURVIVAL AND PROGNOSTIC FACTORS IN SEVERE PNEUMOCYSTIS-CARINII PNEUMONIA REQUIRING MECHANICAL VENTILATION [J].
ELSADR, W ;
SIMBERKOFF, MS .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1988, 137 (06) :1264-1267
[7]  
Glantz S., 1981, PRIMER BIOSTATISTICS
[8]  
HAAGSMAN HP, 1987, J BIOL CHEM, V262, P13877
[9]  
KALES CP, 1987, ARCH INTERN MED, V147, P1413
[10]   INTERACTIONS BETWEEN PLASMA-PROTEINS AND PULMONARY SURFACTANT - PULSATING BUBBLE STUDIES [J].
KEOUGH, KMW ;
PARSONS, CS ;
TWEEDDALE, MG .
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1989, 67 (06) :663-668